Home » Topics » BioWorld Science

BioWorld Science
RSS

Two new combination substudies evaluate pembrolizumab for NSCLC

Jan. 17, 2020

Long-term safety and efficacy of AAV5-hFVIII-SQ gene therapy

Jan. 17, 2020

Evidence of activity seen in phase I trial of RMC-4630 in KRAS-mutant non-small cell lung cancer

Jan. 17, 2020

Oncogenic FHL2-GLI2 fusion identified in sclerosing stromal tumors of the ovary

Jan. 17, 2020

CADM1v8/9 variant useful to detect SCLC

Jan. 17, 2020

ViiV Healthcare UK patents HIV integrase inhibitors

Jan. 17, 2020

Adenosine A2A receptor antagonists identified at Zhejiang Vimgreen Pharma

Jan. 17, 2020

Roche, ETHZ disclose new cannabinoid CB2 receptor ligands

Jan. 17, 2020

New liver X receptor alpha and beta inverse agonists discovered at Phenex-FXR

Jan. 17, 2020

Medshine Discovery identifies isocitrate dehydrogenase mutant inhibitors

Jan. 17, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...